Chemokines on the rise MCP-1 and restenosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 3, 2001, Pages 297-299

  Marie Schmidt, Ann ^a   Stern, David M ^a  

^a College of Physicians and Surgeons of Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1;

CORONARY ARTERY ATHEROSCLEROSIS; EDITORIAL; GENE EXPRESSION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0035090309     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.atv.21.3.297     Document Type: Editorial

References (48)

1. Current role of platelet GP IIb/IIIa inhibitors in acute coronary syndromes
2. The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease
3. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty
4. Chemokines
5. Chemokines: Chemotactic cytokines that mediate inflammation
6. Chemokine-leukocyte interactions
7. Expression of MCP-1 in macrophage-rich areas of human and rabbit atherosclerotic lesions
8. Characterization of atherosclerosis in LDL receptor knockout mice: Macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1/JE
9. MCP-1 accelerates atherosclerosis in ApoE-deficient mice
10. MCP-1 in human atheromatous plaques
11. -/- mice reveals a role for chemokines in the initiation of atherosclerosis
12. Elevated expression of MCP-1 by vascular smooth muscle cells in hypercholesterolemic primates
13. Plasma levels of monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction
14. Elevated circulating levels of C-C chemokines in patients with congestive heart failure
15. Pulmonary granuloma formation in the rat is partially dependent on MCP-1
16. Intervention of crescentic glomerulonephritis by antibodies to MCAF/MCP-1
17. An antagonist of MCP-1 inhibits arthritis in the MRL-1pr mouse model
18. Localization of MCP-1 expression in the central nervous system in EAE and trauma in the rat
19. Increased expression of MCP-1 during active hepatic fibrogenesis
20. MCP-1 acts as a T-lymphocyte chemoattractant
21. Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines
22. C-C chemokines induce the chemotaxis of NK, and IL-2-activated NK cells: Role for G proteins
23. Induction of natural killer cell migration by MCP-1, -2, and -3
24. Through the looking glass: The diverse in vivo activities of chemokines
25. Monocyte chemoattractant protein-1
26. Tissue factor is induced by MCP-1 in human aortic smooth muscle and THP-1 cells
27. PDGF-BB and MCP-1 induce peripheral blood monocytes to express tissue factor
28. Expression of ICAM-1 on rat vascular smooth muscle cells by pro-inflammatory cytokines
29. Cloning and expression of JE, a gene inducible by PDGF and whose product has cytokine-like properties
30. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle
31. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of MCP-1
32. Transgenic MCP-1 in pancreatic islets produces monocyte-rich insulitis without diabetes: Abrogation by a second transgene expressing systemic MCP-1
33. MCP-1: A potential regulator of monocyte recruitment in inflammatory disease
34. Potential role of MCP-1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat
35. Absence of MCP-1 reduces atherosclerosis in LDL receptor-deficient mice
36. Induction of MCP-1 in the small veins of the ischemic and reperfused canine myocardium
37. Primary response genes induced by growth factors and tumor promoters
38. JE mRNA accumulates rapidly in aortic injury and in PDGF-stimulated vascular smooth muscle cells
39. Anti-MCP-1/MCAF antibody inhibits neointimal hyperplasia in injured rat carotid arteries
40. MCP-1 gene expression in injured iliac artery coincides with early appearance of infiltrating monocyte/macrophages
41. Endothelial nuclear factor κB and the initiation of the atherosclerotic lesion
42. Chemokine gene expression in bone marrow stromal cells: Down-regulation with sodium salicylate
43. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
44. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress
45. Role for PPAR-α in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
46. PDGF-specific regulation of the JE promoter in rat aortic smooth muscle cells
47. Nitric oxide regulates MCP-1
48. Inhibition of NO synthesis induces inflammatory changes in MCP-1 expression in rat hearts and vessels